PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Coalition for Epidemic Preparedness and Innovation, London, UK. Electronic address: Gerald.voss@cepi.net.\', \'Coalition for Epidemic Preparedness and Innovation, London, UK.\', \'University of Applied Sciences and Arts, Hanover, Germany.\', \'The Vaccine Centre, Faculty of Infectious Diseases, London School of Hygiene and Tropical Medicine, London, UK.\', \'Center for Immunization Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.\', \'Bill & Melinda Gates Foundation, Seattle, WA, USA.\', \'Brighton Collaboration, Task Force for Global Health, Decatur, GA, USA.\', \'Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.\', \'Vaccines Programme, Wellcome Trust, London, UK.\', \'Food and Drugs Authority, Cantonments, Accra, Ghana.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01382-710.1016/j.vaccine.2021.10.048
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34799142
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
is ?:relation_isRelatedTo_publication of
?:title
  • Meeting report: CEPI consultation on accelerating access to novel vaccines against emerging infectious diseases for pregnant and lactating women, London, 12-13 February 2020.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34799142>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34799142>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all